Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair

Core Insights - Zynex, Inc. has appointed Bret Wise to its Board of Directors, where he will also serve as Chair of the Audit Committee, indicating a strategic move towards enhancing governance and oversight [1][4]. Company Overview - Zynex, Inc. specializes in the manufacture and sale of non-invasive medical devices aimed at pain management, rehabilitation, and patient monitoring [1][9]. - The company was founded in 1996 and has developed a range of medical devices, including those for fluid, sepsis, and laser-based pulse oximetry monitoring systems for hospital use [9]. Leadership and Expertise - Bret Wise brings extensive operational and financial management experience from the medical device industry, having previously served as Chair and CEO of Dentsply International and Executive Chair of Dentsply Sirona [2][3]. - His past roles include Chief Financial Officer of two publicly traded companies and audit partner at KPMG, showcasing a strong background in financial oversight [3]. Strategic Direction - The appointment of Bret Wise is seen as a pivotal moment for Zynex, with a focus on refocusing the company's mission around patient and customer success, integrity, and compliance [2][4]. - The leadership believes that Mr. Wise's financial expertise will significantly enhance Zynex's commitment to high standards of financial oversight and transparency [4].